Pfizer CEO: Developing Omicron Variant Targeted Vaccine

Published on January 10, 2022

Pfizer Inc Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the omicron variant of the coronavirus is the “most likely scenario. “Speaking at the J.P. Morgan Healthcare Conference, Bourla…

Read Full Article (External Site)